WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Saturday, November 18, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email


Personalized Medicine Markets & Scientific and Commercial Aspects to 2026
Wednesday, September 13, 2017

DUBLIN, September 13, 2017 /PRNewswire/ --

The "Personalized Medicine - Scientific and Commercial Aspects" report from Jain PharmaBiotech has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics. Basic technologies of molecular diagnostics play an important role, particularly those for single nucleotide polymorphism (SNP) genotyping.

Several players are involved in the development of personalized therapy. Pharmaceutical and biotechnology companies have taken a leading role in this venture in keeping with their future role as healthcare enterprises rather than mere developers of technologies and manufacturers of medicines.

Ethical issues are involved in the development of personalized medicine mainly in the area of genetic testing. These along with social issues and consideration of race in the development of personalized medicine are discussed. Regulatory issues are discussed mainly with reference to the FDA guidelines on pharmacogenomics.

Increase in efficacy and safety of treatment by individualizing it has benefits in financial terms. Information is presented to show that personalized medicine will be cost-effective in healthcare systems. For the pharmaceutical companies, segmentation of the market may not leave room for conventional blockbusters but smaller and exclusive markets for personalized medicines would be profitable. Marketing opportunities for such a system are described with market estimates from 2016-2026.

Profiles of 323 companies involved in developing technologies for personalized medicines, along with 585 collaborations are included in the part II of the report. Finally the bibliography contains over 750 selected publications cited in the report.The report is supplemented by 83 tables and 39 figures.

Key Topics Covered:

Part I: Scientific & Commercial Aspects

Executive Summary

1. Basic Aspects

2. Molecular Diagnostics in Personalized Medicine

3. Pharmacogenetics

4. Pharmacogenomics

5. Role of Pharmacoproteomics

6. Role of Metabolomics in Personalized Medicine

7. Personalized Biological Therapies

8. Personalized Non-pharmacological Therapies

9. Personalized Medicine in Major Therapeutic Areas

10. Personalized Therapy of Cancer

11. Development of Personalized Medicine

12. Ethical, Legal and Regulatory Aspects of Personalized Medicine .

13. Commercial Aspects of Personalized Medicine

14. References

Part II: Companies

14. Companies Involved in Developing Personalized Medicine

For more information about this report visit https://www.researchandmarkets.com/research/5fmwc8/personalized

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/personalized-medicine-markets--scientific-and-commercial-aspects-to-2026-300518903.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav China Digital TV to Hold 2017 Annual General Meeting on December 29, 2017 | Nov 17, 2017
Nav ASGARD Partners & Co. Announces Engagement by Burst Inc. as Strategic and Capital Markets Advisor | Nov 17, 2017
Nav Upland Software Announces Largest Acquisition to Date, Raises Guidance | Nov 17, 2017
Nav NINJA BLENDER - SOLLUME ESTHÉ Distributor G&J Completes Venture Company Certification by Ministry of SMEs and Startups (MSS) in South Korea | Nov 17, 2017
Nav Global Medical Devices Market 2017 - US Versus International Sales | Nov 17, 2017
Nav Tuniu Announces Management Change and Preliminary Results for the Third Quarter of 2017 | Nov 17, 2017
Nav Global Hydrogels Applications and Markets Report 2017 | Nov 17, 2017
Nav Global $172.6 Billion Therapies Market for Resistant and Recurrent Metastatic Cancer, 2022 | Nov 17, 2017
Nav Global $5.8 Billion Botanical Extracts Market 2017-2022 - Emergence of New Application Areas Accordance With Changing Consumption Trends | Nov 17, 2017
Nav United States Agricultural Machinery Market 2017-2021 - Establishment of Combined Solutions for Optimized Agriculture Practices | Nov 17, 2017
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News